Published in J Biol Chem on November 15, 1996
Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency. PLoS One (2016) 1.42
Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPα. PLoS One (2012) 0.90
MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha. PLoS One (2016) 0.84
Regulation of the human protein C inhibitor gene expression in HepG2 cells: role of Sp1 and AP2. Biochem J (1998) 0.76
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31
The deoxyribonucleic acid unwinding protein of Escherichia coli. Properties and functions in replication. J Biol Chem (1975) 4.87
Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? Transfusion (1999) 4.83
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med (2001) 3.65
Ten proteins required for conversion of phiX174 single-stranded DNA to duplex form in vitro. Resolution and reconstitution. J Biol Chem (1975) 2.48
The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol Microbiol (1996) 2.31
Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann Intern Med (1992) 2.23
Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes (1973) 2.21
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood (2001) 2.15
Location and nucleotide sequence of frdB, the gene coding for the iron-sulphur protein subunit of the fumarate reductase of Escherichia coli. Eur J Biochem (1982) 2.10
Purification of a leucine-specific binding protein from Escherichia coli. Biochem Biophys Res Commun (1970) 2.09
Dimethyl sulfoxide reductase activity by anaerobically grown Escherichia coli HB101. J Bacteriol (1985) 1.99
Purification and characterization of membrane-bound fumarate reductase from anaerobically grown Escherichia coli. Can J Biochem (1979) 1.96
Tellurite reductase activity of nitrate reductase is responsible for the basal resistance of Escherichia coli to tellurite. Microbiology (1997) 1.87
Isolation of an intermediate which precedes dnaG RNA polymerase participation in enzymatic replication of bacteriophage phi X174 DNA. Proc Natl Acad Sci U S A (1976) 1.87
Identification and localization of enzymes of the fumarate reductase and nitrate respiration systems of escherichia coli by crossed immunoelectrophoresis. J Bacteriol (1983) 1.76
Identification of membrane anchor polypeptides of Escherichia coli fumarate reductase. J Bacteriol (1982) 1.71
Biologic effects of leukocytes present in transfused cellular blood products. Blood (1994) 1.65
Nucleotide sequence of the dmsABC operon encoding the anaerobic dimethylsulphoxide reductase of Escherichia coli. Mol Microbiol (1988) 1.63
Transfusion-associated bacterial sepsis: the phoenix rises yet again. Transfusion (1994) 1.63
Inhibition of injury induced thromboatherosclerotic lesions by anti-platelet serum in rabbits. Thromb Haemost (1976) 1.60
The localization of glycerol-3-phosphate dehydrogenase in Escherichia coli. J Membr Biol (1974) 1.55
Nucleotide sequence and gene-polypeptide relationships of the glpABC operon encoding the anaerobic sn-glycerol-3-phosphate dehydrogenase of Escherichia coli K-12. J Bacteriol (1988) 1.53
Selenium metabolism in Escherichia coli. Biometals (1998) 1.50
Fumarate reductase of Escherichia coli. Elucidation of the covalent-flavin component. J Biol Chem (1979) 1.47
Rifampicin-induced immune thrombocytopenia. Br Med J (1970) 1.43
Tellurite-mediated thiol oxidation in Escherichia coli. Microbiology (1999) 1.42
A novel congenital haemostatic defect: combined factor VII and factor XI deficiency. Blood Coagul Fibrinolysis (1992) 1.42
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of white cell reduction on allogeneic alloimmunization. Transfusion (1993) 1.38
The entericidin locus of Escherichia coli and its implications for programmed bacterial cell death. J Mol Biol (1998) 1.37
Cloning and expression of fumarate reductase gene of Escherichia coli. Can J Biochem (1981) 1.37
A binding protein for L-glutamine and its relation to active transport in E. coli. Arch Biochem Biophys (1971) 1.35
Molecular biology, biochemistry and bioenergetics of fumarate reductase, a complex membrane-bound iron-sulfur flavoenzyme of Escherichia coli. Biochim Biophys Acta (1985) 1.35
Fluorotyrosine M13 coat protein: fluorine-19 nuclear magnetic resonance study of the motional properties of an integral membrane protein in phospholipid vesicles. Biochemistry (1978) 1.34
Purification of the membrane-bound and pyridine nucleotide-independent L-glycerol 3-phosphate dehydrogenase from Escherichia coli. Biochem Biophys Res Commun (1972) 1.27
Expression of Escherichia coli TehA gives resistance to antiseptics and disinfectants similar to that conferred by multidrug resistance efflux pumps. Antimicrob Agents Chemother (1997) 1.24
Overproduction of fumarate reductase in Escherichia coli induces a novel intracellular lipid-protein organelle. J Bacteriol (1984) 1.23
Stationary phase expression of a novel Escherichia coli outer membrane lipoprotein and its relationship with mammalian apolipoprotein D. Implications for the origin of lipocalins. J Biol Chem (1995) 1.21
Universal WBC reduction: the case for and against. Transfusion (2001) 1.21
Do blood transfusions improve outcomes related to mechanical ventilation? Chest (2001) 1.19
Molecular cloning and expression of the Escherichia coli dimethyl sulfoxide reductase operon. J Bacteriol (1988) 1.19
Location of a potassium tellurite resistance operon (tehA tehB) within the terminus of Escherichia coli K-12. J Bacteriol (1994) 1.17
Identification and physical characterization of a Col E1 hybrid plasmid containing a catalase gene of Escherichia coli. Can J Biochem Cell Biol (1983) 1.16
The anaerobic sn-glycerol-3-phosphate dehydrogenase: cloning and expression of the glpA gene of Escherichia coli and identification of the glpA products. Can J Biochem (1982) 1.13
Chemical and functional properties of the native and reconstituted forms of the membrane-bound, aerobic glycerol-3-phosphate dehydrogenase of Escherichia coli. J Biol Chem (1978) 1.08
Escherichia coli TehB requires S-adenosylmethionine as a cofactor to mediate tellurite resistance. J Bacteriol (2000) 1.08
Molecular properties of fumarate reductase isolated from the cytoplasmic membrane of Escherichia coli. Can J Biochem (1982) 1.07
The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Biochem J (1987) 1.05
The autoimmune haemolytic anaemias. Br J Haematol (1972) 1.05
An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition. Thromb Haemost (1993) 1.05
The tellurite-resistance determinants tehAtehB and klaAklaBtelB have different biochemical requirements. Microbiology (1995) 1.05
Blood component therapy in anaesthetic practice. Can Anaesth Soc J (1983) 1.04
Immunoglobulins in warm-type autoimmune haemolytic anaemia. Lancet (1969) 1.04
Nucleotide sequence and overexpression of the tellurite-resistance determinant from the IncHII plasmid pHH1508a. Gene (1991) 1.03
Proton translocation coupled to dimethyl sulfoxide reduction in anaerobically grown Escherichia coli HB101. J Bacteriol (1985) 1.03
Glutathione is a target in tellurite toxicity and is protected by tellurite resistance determinants in Escherichia coli. Can J Microbiol (2001) 1.02
Multiple roles for the twin arginine leader sequence of dimethyl sulfoxide reductase of Escherichia coli. J Biol Chem (2000) 1.01
Investigation of solvent accessibility of the fluorotyrosyl residues of M13 coat protein in deoxycholate micelles and phospholipid vesicles. Biochemistry (1979) 1.01
The anaerobic sn-glycerol-3-phosphate dehydrogenase of Escherichia coli. Purification and characterization. J Biol Chem (1981) 1.01
Complementation of growth defect in an ampC deletion mutant of Escherichia coli. FEMS Microbiol Lett (1993) 1.00
Electron paramagnetic resonance spectroscopic characterization of dimethyl sulfoxide reductase of Escherichia coli. Biochemistry (1990) 1.00
Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes. J Biol Chem (1997) 1.00
Structure of fumarate reductase on the cytoplasmic membrane of Escherichia coli. J Bacteriol (1983) 1.00
Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Blood (1984) 0.98
Blood product-associated bacterial sepsis. Transfus Med Rev (1991) 0.97
Organization of dimethyl sulfoxide reductase in the plasma membrane of Escherichia coli. J Bacteriol (1990) 0.95
Dimethyl sulfoxide reductase of Escherichia coli: an investigation of function and assembly by use of in vivo complementation. J Bacteriol (1991) 0.95
Fumarate reductase of Escherichia coli: an investigation of function and assembly using in vivo complementation. Mol Microbiol (1988) 0.95
Backbone dynamics of a model membrane protein: 13C NMR spectroscopy of alanine methyl groups in detergent-solubilized M13 coat protein. Biochemistry (1986) 0.94
Isolation and characterization of the tubular organelles induced by fumarate reductase overproduction in Escherichia coli. J Gen Microbiol (1986) 0.93
Interaction of an engineered [3Fe-4S] cluster with a menaquinol binding site of Escherichia coli DMSO reductase. Biochemistry (1996) 0.93
Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them. Transfus Med Rev (1994) 0.93
Cloning and expression of the glycerol-3-phosphate transport genes of Escherichia coli. Can J Biochem (1978) 0.93
Neither reduced uptake nor increased efflux is encoded by tellurite resistance determinants expressed in Escherichia coli. Can J Microbiol (1995) 0.93
Coordinate regulation of murein peptidase activity and AmpC beta-lactamase synthesis in Escherichia coli. FEBS Lett (1992) 0.93
Use of diethyldithiocarbamate for quantitative determination of tellurite uptake by bacteria. Anal Biochem (1992) 0.93
Retention of heme in axial ligand mutants of succinate-ubiquinone xxidoreductase (complex II) from Escherichia coli. J Biol Chem (2001) 0.92
The covalent attachment of FAD to the flavoprotein of Saccharomyces cerevisiae succinate dehydrogenase is not necessary for import and assembly into mitochondria. Eur J Biochem (1994) 0.92
Engineering a novel iron-sulfur cluster into the catalytic subunit of Escherichia coli dimethyl-sulfoxide reductase. J Biol Chem (1996) 0.92
Determination of an optimal potential window for catalysis by E. coli dimethyl sulfoxide reductase and hypothesis on the role of Mo(V) in the reaction pathway. Biochemistry (2001) 0.92
Overproduction, solubilization, purification and DNA-binding properties of AmpR from Citrobacter freundii. Eur J Biochem (1993) 0.91
Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets. J Clin Invest (1981) 0.91
Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? Transfusion (1997) 0.91
Hydroxylated naphthoquinones as substrates for Escherichia coli anaerobic reductases. Biochem J (1998) 0.91
Bacterial contamination of blood components. Vox Sang (2000) 0.90
Incorporation of 7-deaza dGTP during the amplification step in the polymerase chain reaction procedure improves subsequent DNA sequencing. DNA Seq (1990) 0.90
The effect of amphipaths on the flavin-linked aerobic glycerol-3-phosphate dehydrogenase from Escherichia coli. Can J Biochem (1980) 0.90
Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa. Biochem J (1989) 0.90
Overestimation of fetomaternal haemorrhage by the acid-elution technique in mothers with beta-thalassaemia minor. Transfus Med (1991) 0.89
The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor. Br J Haematol (1984) 0.89
Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall. J Clin Invest (1979) 0.89
RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion (2000) 0.88
Risks associated with blood transfusion in newborn infants. Clin Perinatol (1984) 0.88
The arsenical ATPase efflux pump mediates tellurite resistance. J Bacteriol (1992) 0.87
Prevalence of factor V Leiden in a Canadian blood donor population. CMAJ (1996) 0.87
A prospective study evaluating the lowering of hemoglobin standards for blood donors. Transfusion (1989) 0.87
Alteration of the iron-sulfur cluster composition of Escherichia coli dimethyl sulfoxide reductase by site-directed mutagenesis. Biochemistry (1991) 0.87
The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate. Br J Haematol (1985) 0.87